Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
7
×
Tags
alnylam pharmaceuticals
7
×
boston blog main
life sciences
national blog main
national top stories
biotech
boston top stories
clinical trials
new york blog main
deals
new york top stories
rna interference
amgen
fda
inclisiran
new york
pcsk9 inhibitors
regeneron pharmaceuticals
san francisco blog main
sanofi
startups
alirocumab
boston
evolocumab
hepatitis b
national
novartis
raleigh-durham blog main
raleigh-durham top stories
venture capital
vir biotechnology
abbvie
akouos
alexion pharmaceuticals
allergan
amag pharmaceuticals
amunix
amy schulman
andreas klein
anirvan ghosh
What
medicines
7
×
drug
cholesterol
medco
new
deal
disease
fda
gene
hepatitis
lowering
market
pharmaceuticals
rna
acquire
acquisitions
adds
agreed
alliance
alnylam
announced
areas
aren’t
based
billion
bio
biosciences
bio’s
brii
bringing
brings
car
cash
caught
causing
ceo
clears
closer
collabs
company
Language
unset
Current search:
medicines
×
photo
×
" alnylam pharmaceuticals "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
Brii Bio’s Alliance with VBI Vaccines Adds Hepatitis B Drug to Pipeline
@xconomy.com
5 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”